PHARMASGP HOLDING SE (PSG.DE) Stock Price, Quote, News and Overview

What is the stock price of PHARMASGP HOLDING SE today?

The current stock price of PSG.DE is 28.2 EUR. The price decreased by -1.4% in the last trading session.

What is the ticker symbol for PHARMASGP HOLDING SE stock?

The exchange symbol of PHARMASGP HOLDING SE is PSG and it is listed on the Deutsche Boerse Ag exchange.

On which exchange is PSG.DE stock listed?

PSG.DE stock is listed on the Deutsche Boerse Ag exchange.

What is the price forecast or stock price prediction for PHARMASGP HOLDING SE stock?

6 analysts have analysed PSG.DE and the average price target is 39.53 EUR. This implies a price increase of 40.16% is expected in the next year compared to the current price of 28.2. Check the PHARMASGP HOLDING SE stock analysts ratings, price target forecast and up-and down grades for more detailed information.

What is PHARMASGP HOLDING SE worth?

PHARMASGP HOLDING SE (PSG.DE) has a market capitalization of 338.40M EUR. This makes PSG.DE a Small Cap stock.

How many employees does PHARMASGP HOLDING SE have?

PHARMASGP HOLDING SE (PSG.DE) currently has 89 employees.

What are the support and resistance levels for PHARMASGP HOLDING SE (PSG.DE) stock?

PHARMASGP HOLDING SE (PSG.DE) has a support level at 26.58 and a resistance level at 28.22. Check the full technical report for a detailed analysis of PSG.DE support and resistance levels.

Is PHARMASGP HOLDING SE (PSG.DE) expected to grow?

The Revenue of PHARMASGP HOLDING SE (PSG.DE) is expected to grow by 15.62% in the next year. Check the estimates tab for more information on the PSG.DE EPS, Sales, EBIT and EBITDA future analyst estimates.

Should I buy PHARMASGP HOLDING SE (PSG.DE) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:

• The Technical Analysis (TA) tab contains a technical analysis of PSG.DE, looking at technical quality and support and resistance levels
• The Fundamental Analysis (FA) tab contains a fundamental analysis of PSG.DE, evaluating the profitability, health, valuation and growth aspects
• PHARMASGP HOLDING SE (PSG.DE) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
• PHARMASGP HOLDING SE (PSG.DE) Sales and EPS estimates to see what analysts future expectations are.
• PHARMASGP HOLDING SE (PSG.DE) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
• PHARMASGP HOLDING SE (PSG.DE) Insider and Institutional Ownership to learn about the owners and their transactions.
• PHARMASGP HOLDING SE (PSG.DE) Stock Chart to make your own analysis
• PHARMASGP HOLDING SE (PSG.DE) Latest news and press-releases to stay up to date.

Does PHARMASGP HOLDING SE (PSG.DE) stock pay dividends?

PHARMASGP HOLDING SE (PSG.DE) has a dividend yield of 1.8%. The yearly dividend amount is currently 0.49. Check the full fundamental report for a detailed analysis of PSG.DE dividend history, reliability and sustainability.

When does PHARMASGP HOLDING SE (PSG.DE) report earnings?

PHARMASGP HOLDING SE (PSG.DE) will report earnings on 2025-09-11.

What is the Price/Earnings (PE) ratio of PHARMASGP HOLDING SE (PSG.DE)?

The PE ratio for PHARMASGP HOLDING SE (PSG.DE) is 17.96. This is based on the reported non-GAAP earnings per share of 1.57 and the current share price of 28.2 EUR. Check the full fundamental report for a full analysis of the valuation metrics for PSG.DE.

ChartMill assigns a fundamental rating of 7 / 10 to PSG.DE. PSG.DE gets an excellent profitability rating and is at the same time showing great financial health properties.

Over the last trailing twelve months PSG.DE reported a non-GAAP Earnings per Share(EPS) of 1.57. The EPS increased by 25.55% compared to the year before.

ChartMill assigns a Buy % Consensus number of 80% to PSG.DE. The Buy consensus is the average rating of analysts ratings from 6 analysts.

For the next year, analysts expect an EPS growth of 28.05% and a revenue growth 15.62% for PSG.DE